References and Notes
<A NAME="RD15411ST-1">1</A>
Dhar TGM.
Shen Z.
Gu HH.
Chen P.
Norris D.
Watterson SH.
Ballentine SK.
Fleener CA.
Rouleau KA.
Barrish JC.
Townsend R.
Hollenbaugh DL.
Iwanowicz E.
J. Bioorg. Med. Chem. Lett.
2003,
13:
3557
<A NAME="RD15411ST-2">2</A>
Owa T.
Yoshino H.
Okauchi T.
Okabe T.
Ozawa Y.
Sugi NH.
Yoshimatsu K.
Nagasu T.
Koyanagi N.
Kitoh K.
Bioorg. Med. Chem. Lett.
2002,
12:
2097
<A NAME="RD15411ST-3">3</A>
Yokoi A.
Kuromitsu J.
Kawai T.
Nagasu T.
Sugi
NH.
Yoshimatsu K.
Yoshino H.
Owa T.
Mol. Cancer Ther.
2002,
1:
275
<A NAME="RD15411ST-4">4</A>
Turner SC.
Carroll WA.
White TK.
Gopalakrishnan M.
Coghlan MJ.
Shieh C.-C.
Zhang X.-F.
Parihar
AS.
Buckner SA.
Milicic I.
Sullivan JP.
Bioorg. Med. Chem.
Lett.
2003,
13:
2003
<A NAME="RD15411ST-5">5</A>
Garg NK.
Stoltz BM.
Tetrahedron Lett.
2005,
46:
1997
<A NAME="RD15411ST-6">6</A>
Miyake FY.
Yakushijin K.
Horne DA.
Org.
Lett.
2000,
2:
2121
<A NAME="RD15411ST-7">7</A>
Mąkosza M.
Winiarski J.
J. Org. Chem.
1984,
49:
1494
<A NAME="RD15411ST-8">8</A>
Mąkosza M.
Wojciechowski K.
Chem. Rev.
2004,
104:
2631
<A NAME="RD15411ST-9A">9a</A>
Mąkosza M.
Danikiewicz W.
Wojciechowski K.
Liebigs Ann. Chem.
1988,
203
<A NAME="RD15411ST-9B">9b</A>
Macor JE.
Forman JT.
Post RJ.
Ryan K.
Tetrahedron
Lett.
1997,
38:
1673
<A NAME="RD15411ST-9C">9c</A>
Macor JE.
Wehner JM.
Tetrahedron
Lett.
1993,
34:
349
<A NAME="RD15411ST-9D">9d</A>
Marino JP.
Hurt CR.
Synth.
Commun.
1994,
24:
839
<A NAME="RD15411ST-10">10</A>
Macor JE.
Wehner JM.
Tetrahedron Lett.
1991,
32:
7195
<A NAME="RD15411ST-11A">11a</A>
Wróbel Z.
Mąkosza M.
Synlett
1993,
597
<A NAME="RD15411ST-11B">11b</A>
Wróbel Z.
Mąkosza M.
Tetrahedron
1997,
53:
5501
<A NAME="RD15411ST-12A">12a</A>
Suh JT.
Puma BM.
J.
Org. Chem.
1965,
30:
2253
<A NAME="RD15411ST-12B">12b</A>
Suh JT. inventors; US 3370063.
<A NAME="RD15411ST-13A">13a</A>
Söderberg BCG.
Banini SR.
Turner MR.
Minter AR.
Arrington AK.
Synthesis
2008,
903
<A NAME="RD15411ST-13B">13b</A>
Banini SR.
Turner MR.
Cummings MM.
Söderberg BCG.
Tetrahedron
2011,
67:
3603
<A NAME="RD15411ST-14A">14a</A>
Yu W.
Du Y.
Zhao K.
Org. Lett.
2009,
11:
2417
<A NAME="RD15411ST-14B">14b</A>
Li X.
Du Y.
Liang Zh.
Li X.
Pan Y.
Zhao K.
Org. Lett.
2009,
11:
2643
<A NAME="RD15411ST-14C">14c</A>
El-Araby ME.
Bernacki RJ.
Makara GM.
Pera PJ.
Anderson WK.
Bioorg. Med. Chem.
2004,
12:
2867
<A NAME="RD15411ST-14D">14d</A>
Orlemans EOM.
Schreunder AH.
Conti PGM.
Verboom W.
Reinhoudt DN.
Tetrahedron
1987,
43:
3817
<A NAME="RD15411ST-14E">14e</A>
Wacker DA.
Kasireddy P.
Tetrahedron
Lett.
2002,
43:
5189
<A NAME="RD15411ST-15A">15a</A>
Batcho AD.
Leimgruber W.
Org.
Synth.
1985,
63:
214 ; Org. Synth., Coll. Vol. VII
1990, 34
<A NAME="RD15411ST-15B">15b</A>
Clark RD.
Repke DB.
Heterocycles
1984,
22:
195
<A NAME="RD15411ST-15C">15c</A>
Gribble GW.
J. Chem. Soc., Perkin Trans. 1
2000,
1045
<A NAME="RD15411ST-16A">16a</A>
Clark CI.
White JM.
Kelly DP.
Martin RF.
Lobachevsky P.
Aust.
J. Chem.
1998,
51:
243
<A NAME="RD15411ST-16B">16b</A>
Prashad M.
Vecchia LL.
Prasad K.
Repic O.
Synth. Commun.
1995,
25:
95
<A NAME="RD15411ST-16C">16c</A>
Coe JW.
Vetelino MG.
Bradlee MJ.
Tetrahedron Lett.
1996,
37:
6045
<A NAME="RD15411ST-17">17</A>
Mąkosza M.
Wróbel Z.
Rev. Roum. Chim.
1991,
36:
563 ; Chem. Abstr. 1992, 117, 26036
<A NAME="RD15411ST-18">18</A>
General Procedure
for the Synthesis of Enamines 3a,e,k
The amide 2 (3 mmol) dissolved in dry MeCN (10 mL)
was cooled to -40 ˚C and treated with oxalyl chloride
(3 mmol). The cooling bath was removed, and the reaction mixture allowed
to reach r.t. After evolution of gas ceased (ca. 30 min) the reaction
mixture was cooled to -40 ˚C and treated with
a solution of substrate 1 (1 mmol) and
Et3N (5 mmol) in dry MeCN (10 mL). (In the case of less
soluble sulfones they were added in powdered form to the cooled
Vilsmeier reagent followed by the addition of Et3N).
After stirring for 1 h the reaction mixture was poured into sat.
NH4Cl solution (20 mL), extracted with EtOAc (3 × 20
mL), the extract was dried (Na2SO4), filtered,
evaporated and purified by chromatography.
Enamines 3b-d and 3f-i were
synthesized according to the procedure described previously.¹7
General Procedure for the Synthesis of 3-Cyanoindoles
4
Enamine 3 (1 mmol) in glacial
AcOH (20 mL) was treated with Zn powder (10 mmol) (Note:
a slight exotherm was observed). After stirring for 1 h at r.t.
the mixture was heated to reflux for 1 h. After cooling the solvent
was evaporated to dryness, the residue was dissolved in EtOAc (20
mL), and treated cautiously with sat. NaHCO3 (3 mL).
After filtering through Celite® the solution
was evaporated, and the residue purified by chromatography.
Representative Analytical Data(2
E
,
Z
)-2-(5-Chloro-2-nitrophenyl)-3-(dimethylamino)-3-phenylacrylonitrile
(3a)
White solid, mp 103-106 ˚C. ¹H
NMR (600 MHz, DMSO-d
6): two
isomers, M (major)/N (minor) = 1.2. δ = 2.65
(s, 6 H, M), 3.18 (s, 6 H, N), 7.07 (dd, J = 8.7,
2.2 Hz, 1 H, M), 7.10-7.12 (m,
2 H, M), 7.20-7.24 (m, 2 H, M), 7.29-7.32 (m, 1 H, M), 7.33 (dd, J = 8.7,
2.2 Hz, 1 H, N), 7.43 (d, J = 2.2 Hz,
1 H, M), 7.48-7.55 (m, 5 H, N), 7.51 (d, J = 8.7
Hz, 1 H, M), 7.58 (d, J = 2.2
Hz, 1 H, N), 7.79 (d, J = 8.7
Hz, 1 H, N). MS (EI, 70 eV): m/z (%) = 327
(36), 283 (9), 187 (55), 148 (20), 118 (100), 105 (40). HRMS (EI): m/z calcd for C17H14N3O2
³5Cl:
327.0774; found: 327. 0771.
2-{1-[(4-Methoxyphenyl)methyl]-2-methyl-5-nitro-1
H
-indol-4-yl}-2-[(2
E
,
Z
)-1-methylpyrrolidin-2-ylidene]-acetonitrile
(3d)
Yellow crystals, mp 165-166 ˚C
(hexane-EtOAc).
¹H NMR (500
MHz, DMSO-d
6): two isomers, M (major)/N (minor) = 2.5. δ = 7.74
(d, J = 8.9
Hz, 1 H, M), 7.70 (d, J = 8.9
Hz, 1 H, N), 7.57 (d, J = 8.9
Hz, 1 H, M), 7.56 (d, J = 8.9
Hz, 1 H, N), 6.97-7.01 (m, 2
H, N), 6.93-6.97 (m, 2 H, M), 6.85-6.89 (m, 2 H, M + 2 H, N),
6.45-6.46 (m, 1 H, N), 6.39-6.40
(m, 1 H, M), 5.37-5.47 (m, 2
H, M + 2 H, N), 3.70
(s, 3 H, N), 3.69 (s, 3 H, M), 3.42-3.55 (m, 2 H, M + 2 H, N),
3.34 (s, 3 H, N), 2.92-3.08
(m, 2 H, M), 2.41 (d, J = 0.9
Hz, 3 H, N), 2.41 (d, J = 0.9
Hz, 3 H, M), 2.18 (s, 3 H, M), 2.08-2.22 (m, 2 H, N), 1.96-2.05 (m, 2 H, M), 1.70-1.76 (m, 2 H, N). MS (EI, 70 eV): m/z (%) = 416
(11), 121 (100). HRMS (EI): m/z calcd
for C24H24N4O3: 416.1848; found:
416.1860.
(2
E
,
Z
)-2-(5-Chloro-2-nitrophenyl)-3-pyrrolidin-1-ylpent-2-enenitrile
(3e)
Brown oil. ¹H NMR (500 MHz,
DMSO-d
6): two inseparable isomers, δ = 1.14-1.24
(m, 3 H), 1.68-1.82 (m, 5 H), 2.50-2.70 (m, 2
H), 2.90-3.15 (m, 3 H), 7.45 (br s, 1 H), 7.53-7.59 (m,
1 H), 7.94 (d, J = 8.4
Hz, 1 H). MS (EI, 70 eV): m/z (%) = 305
(31), 235 (12), 165 (100), 110 (15). HRMS (EI): m/z calcd
for C15H16N3
³5ClO2:
305.0931; found: 305.0933.
5-Chloro-2-phenyl-1
H
-indole-3-carbonitrile
(
4a)
Pale
yellow solid, mp >260 ˚C. ¹H
NMR (500 MHz, DMSO-d
6): δ = 7.33
(dd, J = 8.6,
1.9 Hz, 1 H), 7.56-7.60 (m, 2 H), 7.62-7.68 (m,
3 H), 7.96-7.99 (m, 2 H), 12.80 (br s, 1 H). ¹³C NMR
(125 MHz, DMSO-d):²5 δ = 81.7,
114.8, 116.8, 118.0, 124.5, 127.2, 127.6, 129.4, 129.8, 130.8, 134.6,
146.6. MS (EI, 70 eV): m/z (%) = 252
(100), 217 (11), 190 (14). HRMS (EI): m/z calcd
for C15H9N2
³5Cl:
252.0454; found: 252.0449.
6-[(4-Methoxyphenyl)methyl]-7-methyl-2-[3-(methyl-amino)propyl]-3
H
,6
H
-pyrrolo[3,2-
e
]indole-1-carbonitrile
(
4d)
Pale
yellow crystals, mp 177 ˚C (dec., EtOH). ¹H
NMR (500 MHz, DMSO-d
6):²6 δ = 1.87-1.94
(m, 2 H), 2.32 (s, 3 H), 2.41 (s, 3 H), 2.58 (t, J = 7.0
Hz, 2 H), 2.93 (t, J = 7.4
Hz, 2 H), 3.67 (s, 3 H), 5.36 (s, 2 H), 6.55 (s, 1 H), 6.82-6.85
(m, 2 H), 6.89-6.93 (m, 2 H), 7.10 (d, J = 8.7
Hz, 1 H), 7.23 (d, J = 8.7
Hz, 1 H). ¹³C NMR (125 MHz, DMSO-d): δ = 13.0, 25.1,
28.6, 35.7, 45.9, 50.5, 55.5, 81.6, 97.7, 106.0, 106.9, 114.4, 118.3,
118.5, 119.1, 127.8, 129.6, 130.8, 132.4, 136.1, 147.1, 158.7. MS
(EI, 70 eV): m/z (%) = 386
(39), 355 (12), 121 (100). HRMS (EI): m/z calcd
for C24H26N4O: 386.2107; found:
386.2098.
5-Chloro-2-ethyl-1
H
-indole-3-carbonitrile
(
4e)
White
crystals, mp 176-182 ˚C. ¹H
NMR (500 MHz, DMSO-d
6): δ = 1.33
(t, J = 7.6
Hz, 3 H), 2.91 (t, J = 7.6
Hz, 2 H), 7.23 (dd, J = 8.6,
2.0 Hz, 1 H), 7.47 (d, J = 8.6
Hz, 1 H), 7.54 (d, J = 2.0
Hz, 1 H), 12.28 (br s, 1 H). ¹³C NMR (125
MHz, DMSO-d): δ = 13.1,
20.4, 81.7, 113.7, 115.7, 117.1, 122.8, 126.1, 128.3, 133.3, 152.8.
MS (EI, 70 eV):
m/z (%) = 204
(46), 189 (100). HRMS (EI): m/z calcd
for C11H9N2
³5Cl:
204.0454; found: 204.0463
2-(Dimethylamino)-1
H
-benzo[
g
]indole-3-carbonitrile (5)
²7
Yellow
solid. MS (EI, 70 eV): m/z (%) = 235
(100), 220 (54), 192 (24), 164 (8). HRMS (EI): m/z calcd
for C15H13N3: 235.1110; found:
325.1103.
5-Chloro-2-ethyl-1-hydroxy-1
H
-indole-3-carbonitrile
(
7e)
Colorless
crystals, mp 177-183 ˚C (hexane-EtOAc). ¹H NMR
(500 MHz, DMSO-d
6): δ = 1.32
(t, J = 7.6
Hz, 3 H), 2.93 (q, J = 7.6
Hz, 2 H),7.31 (dd, J = 8.7,
2.0 Hz, 1 H), 7.55 (dd, J = 8.7,
0.6 Hz, 1 H), 7.60 (dd, J = 2.0,
0.6 Hz, 1 H), 12.07 (s, 1 H). ¹³C NMR
(125 MHz, DMSO-d): δ = 13.1, 18.6,
77.4, 111.7, 115.7, 117.8, 123.7, 124.2, 127.2, 131.7, 149.5. MS
(EI, 70 eV): m/z (%) = 220
(100), 205 (46), 189 (46). HRMS (EI): m/z calcd
for C11H9N2
³5ClO:
220.0403; found: 220.0405.
<A NAME="RD15411ST-19">19</A>
Mąkosza M.
Goliński J.
Baran J.
J.
Org. Chem.
1984,
49:
1488
<A NAME="RD15411ST-20A">20a</A>
Wojciechowski K.
Mąkosza M.
Tetrahedron
Lett.
1984,
25:
4793
<A NAME="RD15411ST-20B">20b</A>
Wojciechowski K.
Mąkosza M.
Synthesis
1986,
651
<A NAME="RD15411ST-21">21</A>
Heffernan GD.
Coghlan RD.
Manas ES.
McDevitt RE.
Li Y.
Mahaney PE.
Robichaud AJ.
Huselton C.
Alfinito P.
Bray JA.
Cosmi SA.
Johnston GH.
Kenney T.
Koury E.
Winneker RC.
Deecher DC.
Trybulski EJ.
Bioorg. Med. Chem.
2009,
17:
7802
<A NAME="RD15411ST-22">22</A>
Bernotas R.
Lenicek S.
Antane S.
Zhang GM.
Smith D.
Coupet J.
Harrison B.
Schechter LE.
Bioorg. Med. Chem.
Lett.
2004,
14:
5499
<A NAME="RD15411ST-23">23</A>
Bernotas RC.
Antane S.
Shenoy R.
Le V.-D.
Chen P.
Harrison BL.
Robichaud AJ.
Zhang GM.
Smith D.
Schechter LE.
Bioorg. Med. Chem.
Lett.
2010,
20:
1657
<A NAME="RD15411ST-24">24</A>
Wróbel Z.
Wojciechowski K.
Kwast A.
Gajda N.
Synlett
2010,
2435
<A NAME="RD15411ST-25">25</A>
One carbon resonance was not observed.
<A NAME="RD15411ST-26">26</A>
N-H signals not visible.
<A NAME="RD15411ST-27">27</A>
Compound 5 was
isolated in insufficient quantities to obtain full analytical data.